Live from the NIH registry
Studies recruiting near Cedar Rapids right now
Top 25 of 590 recruiting studies, sorted by proximity — each links to its official registry page
Treatment of Moderate to Severe Refractory Crohn's Disease
Crohns Disease
Phase 1, Phase 2
Interventional 39 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Tr1X, Inc.
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Bladder Cancer, Recurrent Bladder Cancer
N/A
Observational 408 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: University of Washington
Biorepository and Registry for Plasma Exchange Patients
Antibody-mediated Rejection, NMO Spectrum Disorder
N/A
Observational 200 participants sought
DeGowin blood Center — Iowa City, Iowa (22.4 mi)
· Sponsor: Charles M Knudson
Type 1 Diabetes Extension Study
Type 1 Diabetes Mellitus, T1DM
N/A
Observational 111 participants sought
University of Iowa Health Care Division of Pediatric Endocrinology — Iowa City, Iowa (22.4 mi)
· Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Phase 1, Phase 2
Interventional 83 participants sought
Research Site — Iowa City, Iowa (22.4 mi)
· Sponsor: AstraZeneca
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Relapsed Refractory Multiple Myeloma
Phase 3
Interventional 508 participants sought
Research Site — Iowa City, Iowa (22.4 mi)
· Sponsor: AstraZeneca
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Multiple conditions
Phase 2
Interventional 150 participants sought
Mercy Hospital — Cedar Rapids, Iowa (3.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
Growth Hormone Deficiency
N/A
Observational 500 participants sought
Ascendis Investigational Site — Iowa City, Iowa (22.4 mi)
· Sponsor: Ascendis Pharma Endocrinology Division A/S
Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG
Advanced Non Small Cell Lung Cancer
Phase 2
Interventional 20 participants sought
University of Iowa Hospitals and Clinics — Iowa City, Iowa (22.4 mi)
· Sponsor: CellSight Technologies, Inc.
From Opinion to Evidence: Multi-site Evaluation of Custom Dynamic Orthosis Best Practices
Foot Injury
N/A
Interventional 35 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Jason Wilken
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
University of Iowa/Holden Comprehensive Cancer Center — Iowa City, Iowa (22.4 mi)
· Sponsor: National Cancer Institute (NCI)
Stroke Thrombectomy and Aneurysm Registry
Stroke, Thromboses, Intracranial
N/A
Observational 40,000 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Medical University of South Carolina
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Staphylococcus Aureus
Phase 1, Phase 2
Interventional 231 participants sought
Research Site — Iowa City, Iowa (22.4 mi)
· Sponsor: AstraZeneca
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
Mercy Hospital — Cedar Rapids, Iowa (3.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
The CONFORM Pivotal Trial
Atrial Fibrillation, Stroke
N/A
Interventional 1,600 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Conformal Medical, Inc
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Gastrointestinal Stromal Tumor (GIST), Gastrointestinal Stromal Cancer
Phase 1
Interventional 157 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Kura Oncology, Inc.
Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial
Post-ligation Cardiac Syndrome
Phase 3
Interventional 316 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: NICHD Neonatal Research Network
Evaluation of the Automated Integration of a Robotics and ECochG System for Use With Cochlear Implant Surgery
Hearing Loss, Sensorineural, Cochlear Implantation
N/A
Interventional 10 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: iotaMotion, Inc.
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Mercy Hospital — Cedar Rapids, Iowa (3.4 mi)
· Sponsor: National Cancer Institute (NCI)
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
Amblyopia
Phase 3
Interventional 252 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Jaeb Center for Health Research
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
Mercy Hospital — Cedar Rapids, Iowa (3.4 mi)
· Sponsor: National Cancer Institute (NCI)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
University of Iowa/Holden Comprehensive Cancer Center — Iowa City, Iowa (22.4 mi)
· Sponsor: National Cancer Institute (NCI)
Dime La VerDAD: Verify, Debunk, and Disseminate
Influenza, COVID-19
N/A
Interventional 1,400 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: University of Chicago
The Pivotal Study of RapidPulseTM Aspiration System
Acute Ischemic Stroke
N/A
Interventional 170 participants sought
State University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: RapidPulse, Inc
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Breast Cancer, Early Breast Cancer
Phase 3
Interventional 4,300 participants sought
Research Site — Iowa City, Iowa (22.4 mi)
· Sponsor: AstraZeneca